Federal regulators are caught between old-guard conservatives who demand continued mRNA funding, Rep. Massie's demand to ...

CHINA| Health officials in Guangdong province in southern China are waging an all-out war against mosquitoes in response to an outbreak of the chikungunya virus that’s sickened thousands with fever, ...

The mosquito-borne disease is sweeping through a province in southern China, which is taking strict measures to quash the ...

HHS Secretary Robert F. Kennedy Jr.’s decision to cut $500 million in federal funding for mRNA vaccine development is based ...

HHS officials are citing an extensive list of studies purported to document harms caused by mRNA vaccines as scientific ...

The rapid rise of the SARS-CoV-2 variant XFG this summer could make it the dominant strain by the start of the fall COVID season, but experts say current vaccines can likely handle the Omicron-based ...

A research project at Emory University is among the 22 grants and contracts that are being cancelled as the U.S. Department of Health and Human Services begins a “coordinated wind-down” of research ...

A new vaccine design pipeline could protect against emerging SARS-CoV-2 variants and pinpoint conserved T-cell epitopes across respiratory viruses.

CSL Seqirus was one of the drugmakers the federal government listed this week as having its mRNA-related work cut. In an ...

Individuals with social risk factors at the time of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have increased risk for subsequent long COVID.

The chapter on Pfizer and BioNTech’s mRNA patent feud with Germany’s CureVac is coming to a close, even as lawsuits over the ...